MANIPULATION OF GENE EXPRESSION WITH SMALL MOLECULES
用小分子操纵基因表达
基本信息
- 批准号:8147684
- 负责人:
- 金额:$ 28.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2012-05-09
- 项目状态:已结题
- 来源:
- 关键词:AnimalsBindingBiological AssayBiomedical ResearchCellsCellular AssayCharacteristicsChromatinCollaborationsCultured CellsDiabetes MellitusGene ChipsGene ExpressionGene TargetingGenerationsGenesGoalsHandHoloenzymesHuman Cell LineIn VitroIsocitrate DehydrogenaseLaboratoriesLeadLibrariesLifeLinkMapsMeasuresMetabolismNuclear ExtractNylonsPeptoidsPermeabilityPrincipal InvestigatorPromoter RegionsPropertyProteinsRNA Polymerase IIRecruitment ActivityReportingSpecificitySynthetic GenesTherapeutic AgentsTransactivationWorkbasechromatin immunoprecipitationcombinatorialdesigngenome-widehuman CREB1 proteinimprovedisletnovelprogramspromoterresearch studysmall moleculetooltranscription factor
项目摘要
The goal of this project is to create cell permeable synthetic molecules capable of activating the expression of specific genes. The "synthetic transcription factor mimics" would be capable of localizing to a specific promoter region and recruiting the transcriptional machinery to a nearby gene, thus mimicking a basic function of native transactivator proteins. These molecules would be tools of outstanding utility in biomedical research and could potentially be elaborated into a new class of therapeutic agents.
It is envisioned that a synthetic activator could be created by fusing together a DMA-binding molecule, specifically a hairpin polyamide with the appropriate DMA recognition characteristics, with a molecule capable of binding the RNA polymerase II holoenzyme, thus recruiting it to the target promoter. There is considerable evidence from our laboratory and others that this is a valid approach, but while synthetic activators capable of functioning in nuclear extracts have been reported, the goal of molecules that function
in living cells remains elusive. We have recently made an exciting breakthrough with the discovery of a cell permeable peptoid that functions as an activation domain equivalent in living cells. This is the first observation of such activity. We plan to link this peptoid and improved derivatives to hairpin polyamides with appropriate sequence recognition properties to create cell permeable synthetic activators. These compounds will be employed to manipulate metabolism in cell lines and human islets. In particular, we will
attempt to activate the Nkx6.1 gene and the cytosolic, NADPH-dependent isocitrate dehydrogenase gene in islets and determine the effect of this stimulation of the metabolism of the cell. These studies will be in collaboration with the Newgard laboratory. Following the lead of recent results in the Newgard laboratory, we also plan to use genome-wide chromatin immunoprecipitation assays to help to identify direct Nkx6.1 target
genes and will also then design synthetic molecules to turn on these genes as well.
Throughout the course of this project, consistent efforts will be made to develop ever more potent synthetic activators. To do so, we will take advantage of a novel cell-based screen that we have developed which allows synthetic combinatorial libraries to be screened for activation domain mimics directly.
Furthermore, we will also set up cellular assays to optimize polyamides for binding to the desired promoters.
该项目的目标是创造能够激活特定基因表达的细胞渗透性合成分子。“合成转录因子模拟物”能够定位于特定的启动子区域并将转录机制募集到附近的基因,从而模拟天然反式激活蛋白的基本功能。这些分子将是生物医学研究中具有突出实用性的工具,并可能被精心制作成一类新的治疗剂。
可以设想,合成激活剂可以通过将DMA结合分子(特别是具有适当DMA识别特征的发夹聚酰胺)与能够结合RNA聚合酶II全酶的分子融合在一起,从而将其募集到靶启动子来产生。我们的实验室和其他实验室有相当多的证据表明这是一种有效的方法,但是尽管已经报道了能够在核提取物中发挥作用的合成活化剂,但发挥作用的分子的目标是
活细胞中的基因仍然难以捉摸。我们最近取得了一个令人兴奋的突破,发现了一种细胞可渗透的类肽,在活细胞中起着激活结构域等同物的作用。这是对这种活动的第一次观察。我们计划将这种类肽和改进的衍生物与具有适当序列识别特性的发夹聚酰胺连接起来,以创造细胞可渗透的合成激活剂。这些化合物将用于操纵细胞系和人类胰岛中的代谢。特别是要
试图激活胰岛中的Nkx6.1基因和胞质NADPH依赖性异柠檬酸脱氢酶基因,并确定这种刺激对细胞代谢的影响。这些研究将与Newgard实验室合作。根据Newgard实验室最近的结果,我们还计划使用全基因组染色质免疫沉淀分析来帮助识别直接的Nkx6.1靶点。
然后设计合成分子来开启这些基因。
在整个项目过程中,将不断努力开发更有效的合成活化剂。为此,我们将利用我们开发的一种新的基于细胞的筛选,该筛选允许直接筛选合成的组合文库的激活结构域模拟物。
此外,我们还将建立细胞测定来优化聚酰胺与所需启动子的结合。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas J. Kodadek其他文献
Thomas J. Kodadek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas J. Kodadek', 18)}}的其他基金
Establishment of a Cell-Based Screening Platform for DNA Encoded Libraries
DNA编码文库细胞筛选平台的建立
- 批准号:
10646635 - 财政年份:2023
- 资助金额:
$ 28.34万 - 项目类别:
Molecular Cloaking Devices for Manipulation of Cysteine Post-Translational Modifications
用于操纵半胱氨酸翻译后修饰的分子隐藏装置
- 批准号:
10507541 - 财政年份:2022
- 资助金额:
$ 28.34万 - 项目类别:
Phenotypic screening using DNA-encoded libraries
使用 DNA 编码文库进行表型筛选
- 批准号:
10238888 - 财政年份:2018
- 资助金额:
$ 28.34万 - 项目类别:
Phenotypic screening using DNA-encoded libraries
使用 DNA 编码文库进行表型筛选
- 批准号:
10622655 - 财政年份:2018
- 资助金额:
$ 28.34万 - 项目类别:
Phenotypic screening using DNA-encoded libraries
使用 DNA 编码文库进行表型筛选
- 批准号:
10001013 - 财政年份:2018
- 资助金额:
$ 28.34万 - 项目类别:
Discovery of Potent Proteasome Agonists to Improve Proteostasis
发现有效的蛋白酶体激动剂以改善蛋白质稳态
- 批准号:
9388111 - 财政年份:2017
- 资助金额:
$ 28.34万 - 项目类别:
Discovery of antibody biomarkers for Alzheimer’s Disease
阿尔茨海默病抗体生物标志物的发现
- 批准号:
9092101 - 财政年份:2016
- 资助金额:
$ 28.34万 - 项目类别:
Discovery of antibody biomarkers for Alzheimer’s Disease
阿尔茨海默病抗体生物标志物的发现
- 批准号:
9265411 - 财政年份:2016
- 资助金额:
$ 28.34万 - 项目类别:
HTS for Direct Targeting of the Transcription Factor MITF
用于直接靶向转录因子 MITF 的 HTS
- 批准号:
9109569 - 财政年份:2014
- 资助金额:
$ 28.34万 - 项目类别:
Discovery and Treatment of the Early Autoimmune Reaction In Type 1 Diabetes
1 型糖尿病早期自身免疫反应的发现和治疗
- 批准号:
8240614 - 财政年份:2011
- 资助金额:
$ 28.34万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 28.34万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 28.34万 - 项目类别:
Continuing Grant
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 28.34万 - 项目类别:
Discovery Projects
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 28.34万 - 项目类别:
Fellowship
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 28.34万 - 项目类别:
Research Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 28.34万 - 项目类别:
Standard Grant
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 28.34万 - 项目类别:
Standard Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 28.34万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 28.34万 - 项目类别:
Discovery Projects
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 28.34万 - 项目类别:
Research Grant














{{item.name}}会员




